ÌÇÐÄ´«Ã½

Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
ÌÇÐÄ´«Ã½

The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-Small Cell Lung Cancer.

ÌÇÐÄ´«Ã½

The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-Small Cell Lung Cancer. The Annals of thoracic surgery Kim, S. S., Cooke, D. T., Kidane, B., Tapias, L. F., Lazar, J. F., Awori Hayanga, J. W., Patel, J. D., Neal, J. W., Abazeed, M. E., Willers, H., Shrager, J. B. 2024

Abstract

BACKGROUND: The contemporary management and resectability of locally advanced lung cancer are undergoing significant changes as new data emerge regarding immunotherapy and targeted treatments. The objective of this document is to review the literature and present consensus among a group of multidisciplinary experts to guide the determination of resectability and management of locally advanced non-small cell lung cancer (NSCLC) in the context of contemporary evidence.METHODS: The Society of Thoracic Surgeon Workforce on Thoracic Surgery assembled a multidisciplinary expert panel comprised of thoracic surgeons and medical and radiation oncologists with established expertise in the management of lung cancer. A focused literature review was performed, and expert consensus statements were developed using a modified Delphi process to address three major themes: (1) Assessing Resectability and Multidisciplinary Management of Locally Advanced Lung Cancer, (2) Neoadjuvant (including peri-operative) therapy, and (3) Adjuvant therapy.RESULTS: A consensus was reached on 19 recommendations. These consensus statements reflect updated insights on resectability and multidisciplinary management of locally advanced lung cancer based on the latest literature and current clinical experience, mainly focusing on the appropriateness of surgical therapy and emerging data regarding neoadjuvant and adjuvant therapies.CONCLUSIONS: Despite the complex decision-making process in managing locally advanced lung cancer, this expert panel agreed on several key recommendations. This document provides guidance for thoracic surgeons and other medical professionals in the optimal management of locally advanced lung cancer based on the most updated evidence and literature.

View details for

View details for